Analystreport

SAGE Therapeutics Inc (NASDAQ: SAGE) had its price target lowered by analysts at Goldman Sachs Group Inc from $227.00 to $263.00.

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations